Webster Bank’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-2,006
Closed -$1K 567
2020
Q4
$1K Hold
2,006
﹤0.01% 533
2020
Q3
$5K Hold
2,006
﹤0.01% 474
2020
Q2
$7K Hold
2,006
﹤0.01% 446
2020
Q1
$8K Buy
+2,006
New +$6.61K ﹤0.01% 427

Other funds holding BMY.RT

Webster Bank's BMY.RT Position: Q1 2021 in Review

Webster Bank sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 2,006 shares — an estimated $1K sold.

Webster Bank first reported a position in BMY.RT in Q1 2020 and held it in 4 quarters. The position peaked at $8K in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Webster Bank reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Webster Bank sold 2,006 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $1K.
  • Webster Bank first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q1 2020 and held it in 4 quarters.
  • Webster Bank's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $8K in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Webster Bank's 13F filing for Q1 2021, filed 7 May 2021.